(Q46832056)

25 December 2017

title

Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. (English)

1 reference

25 December 2017

author name string

Sertoz RY

1

1 reference

25 December 2017

Erensoy S

2

1 reference

25 December 2017

Pas S

3

1 reference

25 December 2017

Akarca US

4

1 reference

25 December 2017

Ozgenc F

5

1 reference

25 December 2017

Yamazhan T

6

1 reference

25 December 2017

Ozacar T

7

1 reference

25 December 2017

Niesters HG

8

1 reference

25 December 2017

publication date

1 October 2005

1 reference

25 December 2017

published in

Journal of Chemotherapy

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

514-520

1 reference

25 December 2017

The mechanisms of action of antivirals against hepatitis B virus infection

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Hepatitis B virus infection: resistance to antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.514

10.1179/JOC.2005.17.5.514

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16323440

1 reference

25 December 2017